Delivery Order SPE2DB22D2005-SPE2DB25FJQG3
- Not listed
- The Defense Logistics Agency awarded a $2,113.94 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120-count packaging) under a firm fixed-price contract valued at $1,014.56. This non-set-aside delivery order represents a small-value pharmaceutical procurement with a completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,215.46 for 30-count units of Mesalamine 1000mg on July 23, 2025, with an ultimate completion date of August 19, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,320.87. This is a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The order is scheduled for ultimate completion on July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,226.47 fixed-price delivery order is for the supply of 4,565,481,647 units of the medication Mesalamine DR 1.2 GM Tablet, with a performance period ending on August 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency Troop Support Medical awarded a $102,720 delivery order to Amerisourcebergen Drug Corporation for 1,000 units of 1,000 mg mesalamine supplements. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for the pharmaceutical products to be shipped to a facility in Conshohocken, Pennsylvania by September 25, 2023. Amerisourcebergen will serve as the prime contractor on the fixed-price order, which supports the...
- The Defense Logistics Agency Troop Support Medical awarded a $4,733.86 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 120 tablets of 1.2 gm mesalamine. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 7-8, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $199,000 to Amerisourcebergen Drug Corporation for the supply of 120 capsules of 0.375 gram Mesalamine ER. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 15-16, 2023. This delivery order was issued against an existing DLA contract vehicle to fulfill requirements for this gastrointestinal drug, which is used to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical sourcing and distribution company. The $1,879.92 contract is for the supply of 180 count capsules of the drug Mesalamine DR 400 mg. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,412.14 contract is for the delivery of 180 tablets of 800 mg mesalamine delayed-release medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJQG3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contracts with the Defense Logistics Agency covering a broad spectrum of medications and medical supplies. The company's federal procurement history demonstrates its capability to fulfill diverse medical supply requirements through open competition, ranging from small-value transactions to substantial orders exceeding $45,000. This particular delivery order for Mesalamine DR—an anti-inflammatory medication used to treat inflammatory bowel disease—represents one of numerous pharmaceutical deliveries the contractor executes under its comprehensive DLA contract vehicle to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 7/23/25 |